Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside

被引：38
作者：
Furukawa, Toru [1 ]
机构：
[1] Tokyo Womens Med Univ, Int Res & Educ Inst Integrated Med Sci, Shinjuku Ku, Tokyo 1628666, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2008年 / 43卷 / 12期
关键词：
pancreatic cancer; molecular targeting; RAS-MAPK; PI3K-AKT; hedgehog;
D O I：
10.1007/s00535-008-2226-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Current medical interventions for pancreatic cancer are insufficient. Recent molecular investigations have elucidated complex genetic mechanisms of cancer that especially involve multiple signal transduction pathways; this enables us to develop molecular medicines targeting specific genetic molecules in the pathways. These molecular medicines seem to promise clues for curing cancers, including pancreatic cancer. This review describes current knowledge and perspectives regarding the development of molecular medicines for pancreatic cancer by focusing on growth factor receptor systems and three major signal transduction pathways: the RAS-MAPK, PI3K-AKT-mTOR, and hedgehog pathways.
引用
收藏
页码：905 / 911
页数：7
相关论文
共 50 条
  • [1] Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside
    Toru Furukawa
    Journal of Gastroenterology, 2008, 43 : 905 - 911
  • [2] Pancreatic cancer: from bench to bedside
    Ma, Yaokai
    Wu, Qing
    Li, Xin
    Gu, Xiaoqiang
    Xu, Jiahua
    Yang, Jinzu
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (23)
  • [3] The impact of molecular classification based on the transcriptome of pancreatic cancer: from bench to bedside
    Yan Deng
    Ting Zhou
    Jia-long Wu
    Yong Chen
    Cheng-yi Shen
    Mei Zeng
    Tianwu Chen
    Xiao-Ming Zhang
    Chinese Journal of Academic Radiology, 2020, 3 : 67 - 75
  • [4] The impact of molecular classification based on the transcriptome of pancreatic cancer: from bench to bedside
    Deng, Yan
    Zhou, Ting
    Wu, Jia-long
    Chen, Yong
    Shen, Cheng-yi
    Zeng, Mei
    Chen, Tianwu
    Zhang, Xiao-Ming
    CHINESE JOURNAL OF ACADEMIC RADIOLOGY, 2020, 3 (02) : 67 - 75
  • [5] From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
    Kunk, Paul R.
    Bauer, Todd W.
    Slingluff, Craig L.
    Rahma, Osama E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [6] The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside
    Gorgulu, Kivanc
    Diakopoulos, Kalliope N.
    Kaya-Aksoy, Ezgi
    Ciecielski, Katrin J.
    Ai, Jiaoyu
    Lesina, Marina
    Algul, Hana
    CELLS, 2020, 9 (04)
  • [7] Molecular targeting therapy for pancreatic cancer
    Henry Q. Xiong
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S69 - S77
  • [8] Molecular targeting therapy for pancreatic cancer
    Xiong, HQ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (Suppl 1) : S69 - S77
  • [9] Melatonin and pancreatic cancer: Current knowledge and future perspectives
    Tamtaji, Omid Reza
    Mirhosseini, Naghmeh
    Reiter, Russel J.
    Behnamfar, Morteza
    Asemi, Zatollah
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 5372 - 5378
  • [10] Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
    Yang, Feng
    Jin, Chen
    Jiang, Yongjian
    Li, Ji
    Di, Yang
    Ni, Quanxing
    Fu, Deliang
    CANCER TREATMENT REVIEWS, 2011, 37 (08) : 633 - 642
12345